Long acting beta agonist and steroid inhaler

Patients requiring oral corticosteroids should be weaned slowly from systemic corticosteroid use after transferring to Advair Diskus. Prednisone reduction can be accomplished by reducing the daily prednisone dose by mg on a weekly basis during therapy with Advair Diskus. Lung function (mean forced expiratory volume in 1 second [FEV 1 ] or morning peak expiratory flow [AM PEF]), beta-agonist use, and asthma symptoms should be carefully monitored during withdrawal of oral corticosteroids. In addition, patients should be observed for signs and symptoms of adrenal insufficiency, such as fatigue, lassitude, weakness, nausea and vomiting, and hypotension.

Long acting beta agonist and steroid inhaler

long acting beta agonist and steroid inhaler

Media:

long acting beta agonist and steroid inhalerlong acting beta agonist and steroid inhalerlong acting beta agonist and steroid inhalerlong acting beta agonist and steroid inhalerlong acting beta agonist and steroid inhaler